Fresenius Corporate Profile
Financials
2018 Annual Revenue
$16.55 billion
2018 Gross Profit
$5.16 billion
2018 Annual Net Income
$1.98 billion
2018 Fiscal Year Net Income Growth
54.84%
Credit Rating
Fresenius Medical Care Holdings Inc. is a wholly-owned subsidiary of Fresenius Medical Care AG & Co., which is Investment Grade BBB-
Fresenius Corporate Profile
Fresenius Medical Care (NYSE: FMS) is a Germany-based company that provides dialysis and related products, inpatient/outpatient care products, and services such as engineering to hospitals and related facilities. Fresenius operates more than 2,100 dialysis centers in North America and has over 100,000 employees. These facilities provide medically-necessary renal care to hundreds of thousands of patients requiring dialysis because of chronic kidney failure, a condition that affects more than 2.1 million individuals globally. Dialysis is a medically-necessary and routine procedure that typically requires three visits per weak. Demand is projected to grow due to the increasing rate of obesity in America, which leads to kidney failure in approximately 44% of cases.